Notably, a number of studies have shown the S protein as a leading target for the development of SARS-CoV-2 vaccines; therefore, most of the COVID-19 vaccines currently developed and available are S protein-, specifically RBD-based vaccines [3,4,8,9,10,11]. Here, PROS1 is linked to COVID-19.